TWO SIGMA INVESTMENTS, LP - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$1,932,819
-35.0%
107,618
-26.4%
0.01%
-28.6%
Q2 2023$2,972,447
+92.5%
146,138
+106.0%
0.01%
+75.0%
Q1 2023$1,543,763
+87.0%
70,945
+166.4%
0.00%
+33.3%
Q4 2022$825,419
+142.8%
26,635
+58.9%
0.00%
+200.0%
Q2 2022$340,000
-68.2%
16,762
-61.2%
0.00%
-66.7%
Q1 2022$1,069,000
-64.4%
43,211
-50.1%
0.00%
-50.0%
Q4 2021$3,007,000
-23.5%
86,532
-40.3%
0.01%
-33.3%
Q3 2021$3,932,000
-27.3%
144,993
-30.5%
0.01%
-25.0%
Q2 2021$5,409,000
-12.5%
208,603
-27.2%
0.01%
-25.0%
Q1 2021$6,179,000
-7.6%
286,730
-7.8%
0.02%
-15.8%
Q4 2020$6,688,000
+69.1%
311,077
+16.0%
0.02%
+35.7%
Q3 2020$3,955,000
-39.3%
268,113
-8.0%
0.01%
-56.2%
Q2 2020$6,513,000
+61.9%
291,536
+2.4%
0.03%
-3.0%
Q1 2020$4,023,000
+2.5%
284,735
+17.9%
0.03%
+175.0%
Q4 2019$3,924,000
+31.8%
241,494
+183.8%
0.01%
+20.0%
Q3 2019$2,977,000
+18.4%
85,089
+90.9%
0.01%
+25.0%
Q2 2019$2,514,000
+135.6%
44,563
+205.1%
0.01%
+166.7%
Q1 2019$1,067,000
-87.5%
14,608
-83.0%
0.00%
-87.0%
Q3 2018$8,551,000
-26.9%
85,705
-47.9%
0.02%
-34.3%
Q2 2018$11,697,000
+4398.8%
164,657
+6486.3%
0.04%
+3400.0%
Q1 2018$260,000
-83.5%
2,500
-84.0%
0.00%
-80.0%
Q4 2017$1,578,000
+48.0%
15,663
-48.6%
0.01%
+25.0%
Q3 2017$1,066,00030,5010.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$81,462,73111.84%
EcoR1 Capital, LLC 7,521,024$233,076,5347.09%
5AM Venture Management, LLC 357,733$11,086,1462.98%
Boxer Capital, LLC 1,300,000$40,287,0002.12%
Frazier Life Sciences Management, L.P. 899,700$27,881,7031.73%
Palo Alto Investors LP 431,024$13,357,4341.14%
Logos Global Management LP 250,000$7,747,5000.91%
BRAIDWELL LP 726,122$22,502,5210.75%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,161,826$36,004,9880.74%
Rock Springs Capital Management LP 576,600$17,868,8340.43%
View complete list of ANAPTYSBIO INC shareholders